Covered recipient · General Payments record
COREY STAURT MAAS
Allopathic & Osteopathic Physicians Surgery Plastic and Reconstructive Surgery
General Payments · PY2018–2024
$386,607.37
- Reported across 344 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $22,420.00 | 3 |
| Food and Beverage | $1,058.06 | 18 |
| Travel and Lodging | $772.31 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $24,005.17 | 21 |
| REVANCE THERAPEUTICS, INC. | $216.61 | 3 |
| Pacira Pharmaceuticals Incorporated | $28.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $112.32 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917321 | CMS |
| ABBVIE INC. | $130.00 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917323 | CMS |
| ABBVIE INC. | $12,075.00 | 02/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104917325 | CMS |
| ABBVIE INC. | $103.48 | 03/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104917327 | CMS |
| ABBVIE INC. | $71.58 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917329 | CMS |
| ABBVIE INC. | $86.13 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917331 | CMS |
| ABBVIE INC. | $16.78 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917333 | CMS |
| ABBVIE INC. | $366.43 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104917335 | CMS |
| ABBVIE INC. | $237.90 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104917337 | CMS |
| ABBVIE INC. | $69.56 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917339 | CMS |
| ABBVIE INC. | $64.50 | 05/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104917341 | CMS |
| ABBVIE INC. | $24.55 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917343 | CMS |
| ABBVIE INC. | $24.55 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917345 | CMS |
| ABBVIE INC. | $61.65 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917347 | CMS |
| ABBVIE INC. | $1,145.00 | 06/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104917349 | CMS |
| ABBVIE INC. | $18.43 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917351 | CMS |
| ABBVIE INC. | $130.00 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917353 | CMS |
| ABBVIE INC. | $18.57 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917355 | CMS |
| ABBVIE INC. | $32.73 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917357 | CMS |
| ABBVIE INC. | $9,200.00 | 10/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104917359 | CMS |
| ABBVIE INC. | $16.01 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104917361 | CMS |
| Pacira Pharmaceuticals Incorporated | $28.59 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151242845 | CMS |
| REVANCE THERAPEUTICS, INC. | $33.47 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923544 | CMS |
| REVANCE THERAPEUTICS, INC. | $145.38 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923546 | CMS |
| REVANCE THERAPEUTICS, INC. | $37.76 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923548 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.